Hueso et al
If a reasonable settlement cannot be reached, the case may go to trial
Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease
Researchers should review published literature and protocol guidelines before determining quantities for scientific investigation
The safety profile of cagrilintide-semaglutide was broadly consistent with that reported for other incretin-based therapies, although gastrointestinal adverse events and treatment discontinuations occurred more frequently than with either semaglutide or cagrilintide alone, highlighting the importance of careful patient selection and long-term adherence
However, there are certainly a number of side effects linked to high Melanotan doses: Some dose-ranging studies have found that higher doses of Melanotan produce gastrointestinal issues, lethargy, and moderate fatigue [17]